Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: A cancer research campaign trial

Journal of Clinical Oncology

Volumn 12, Issue 9, 1994, Pages 1806-1813

  Souhami, R L ^a   Rudd, R ^b   Ruiz De Elvira, M C ^b   James, L ^b   Gower, N ^b   Harper, P G ^b   Tobias, J S ^b   Partridge, M R ^b   Davison, A G ^b   Trask, C ^b   Spiro, S G ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; BIOPSY; BLOOD TOXICITY; BRONCHOSCOPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; THORAX RADIOGRAPHY; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; REMISSION INDUCTION; SURVIVAL RATE; VINCRISTINE;

EID: 0027948376     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1994.12.9.1806     Document Type: Article

References (19)

1. Souhami RL, Law K: Longevity in small cell lung cancer. Br J Cancer 61:584-589, 1990
2. Davis S, Wright PW, Schulman SF, et al: Long-term survival in small cell carcinoma of the lung: A population experience. J Clin Oncol 3:80-91, 1985
3. Figueredo AT, Hryniuk WM, Strautmanis I, et al: Co-trimoxazole prophylaxis during high-dose chemotherapy of small cell lung cancer. J Clin Oncol 3:54-64, 1985
4. Ihde D, Mulshine J, Kramer B, et al: Randomized trial of high vs standard dose VP16/cisplatin in extensive small cell lung cancer (SCLC). Lung Cancer 7:A506, 1991 (suppl)
5. Souhami RL, Finn GP, Gregory WM, et al: High dose cyclophosphamide in small cell carcinoma of the lung. J Clin Oncol 3:958-963, 1985
6. Humblet Y, Symann M, Bosly A, et al: Late intensification chemotherapy with autologous bone marrow transplantation in selected small cell carcinoma of the lung: A randomized study. J Clin Oncol 5:1864-1873, 1987
7. Crawford J, Ozer H, Stoller R, et al: Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Eng J Med 315:164-170, 1991
8. Bronchud MH, Scarffe JH, Thatcher N, et al: Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 56:809-813, 1987
9. Miles DW, Earl HM, Souhami RL, et al: Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer. J Clin Oncol 9:280-285, 1991
10. Taylor CW, Crowley J, Williamson SK, et al: Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: A Southwest Oncology Group pilot study. J Clin Oncol 8:1811-1817, 1990
11. Murray N, Shah A, Osoba D, et al: Intensive weekly chemotherapy for the treatment of extensive-stage small cell lung cancer. J Clin Oncol 9:1632-1638, 1991
12. Feld R, Evans WK, Coy P, et al: Canadian multicenter randomised trial comparing sequential and alternating administration of two non-cross resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. J Clin Oncol 5:1401-1409, 1987
13. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 35:1-39, 1977
14. Miles DW, Rudd RM, Trask CWL, et al: Received dose-intensity: A randomised trial of weekly chemotherapy with and without granulocyte colony stimulating factor in small cell lung cancer. J Clin Oncol 12:77-82, 1994
15. Souhami RL, Bradbury I, Geddes DM, et al: Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res 45:2878-2882, 1985
16. Rawson NSB, Peto J: An overview of prognostic factors in small cell lung cancer. A report from the sub-committee for the Management of Lung Cancer of the UK Co-ordinating Committee. Br J Cancer 61:597-604, 1990
17. Arriagada R, Le Chevalier T, Pignon J-P, et al: Initial chemotherapeutic doses and survival in patients with limited small cell lung cancer. N Engl J Med 329:1848-1852, 1993
18. Sculier JP, Paesmans M, Bureau G, et al: Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: A phase III randomized study conducted by the European Lung Cancer Working Party. J Clin Oncol 11:1858-1865, 1993
19. Murray N, Coy P, Pater JL, et al: Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 11:336-344, 1993